Clinical Trials Logo

Clinical Trial Summary

This is a prospective, open label, non-comparative clinical investigation to evaluate the performance of a Fungal Nail Treatment on the visual signs of onychomycosis.

The Fungal Nail Treatment is a CE Marked Class I Medical Device and is commercially available as an over-the-counter product.

The ability of the Fungal Nail Treatment to treat the visual signs of mild fungal toenail infections will be determined by a reduction in the surface area of the infection over time. This will be assessed through visual quantification of the infected area from baseline, as measured by image analysis, throughout the treatment period, where subjects will follow instructions for use on the product pack and self-treat for the duration of the investigation or until their condition has resolved. Both subject and podiatrist will assess the improvement of signs and symptoms of the target nail.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02546258
Study type Interventional
Source Reckitt Benckiser Healthcare (UK) Limited
Contact
Status Completed
Phase N/A
Start date August 25, 2014
Completion date November 21, 2014

See also
  Status Clinical Trial Phase
Completed NCT01302119 - Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail Phase 3
Completed NCT01270971 - Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail Phase 3
Completed NCT02131363 - A Clinical Investigation to Evaluate the Safety and Performance of a Treatment Kit for Ingrowing Toenail N/A
Recruiting NCT01920178 - Evaluation Study for the Efficacy and Safety of PinPointe FootLaser in Treatment for Onychomycosis N/A